{"doi":"10.1016/j.pecinn.2024.100263","title":"Developing and testing a web-based platform for antiretroviral therapy (ART) adherence support among adolescents and young adults (AYA) living with HIV","abstract":"Objective: Describe the development and testing of a web-based platform for antiretroviral treatment (ART) adherence support among HIV+ adolescents and young adults (AYA) in a randomized controlled trial (RCT). Methods: A seven-member multi-disciplinary team operationalized the flat, password protected, web-based platform. Manualized protocols guided the objectives and content for each of the eight web-based sessions. Team members evaluated usability and content validity. Client satisfaction and perceived ease of use was evaluated with the first ten HIV+ AYA participants. Results: The web-based platform was developed, evaluated, refined, implemented and pilot tested between September 2020 to April 2022. Usability was rated as high; the evaluation of content validity showed an excellent fit between session content and objectives. HIV+ AYA participants (mean age = 24.2 years) were satisfied with the quality, type, and amount of support/education received, and found the platform easy to use, operate, and navigate. Average time spent per session was 6.5 min. Conclusion: Findings support the usability, validity, acceptability, and feasibility of this web-based platform for ART adherence support among HIV+ AYA. Innovation: Our research and findings are responsive to research gaps and the need for transparency in the methodological development and testing of web-based control arms for ART adherence support among HIV+ AYA.","journal":"PEC Innovation","year":2024,"id":467274,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":3,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9336,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1299689,"name":"Maurade Gormley","orcid":"0000-0001-8988-5068","position":1,"is_corresponding":false},{"id":762106,"name":"Eva Liang","orcid":"0000-0003-1423-3115","position":2,"is_corresponding":false},{"id":1300065,"name":"Claire Loughran","orcid":null,"position":3,"is_corresponding":false},{"id":347429,"name":"Allison Vorderstrasse","orcid":"0000-0001-8770-1851","position":4,"is_corresponding":false},{"id":1299690,"name":"David R. Garcia","orcid":"0000-0002-6026-2462","position":5,"is_corresponding":false},{"id":880593,"name":"Michael Rosenberg","orcid":"0000-0002-9950-5775","position":6,"is_corresponding":false},{"id":1299691,"name":"Jason Fletcher","orcid":"0000-0002-4760-7200","position":7,"is_corresponding":false},{"id":779538,"name":"Lloyd A. Goldsamt","orcid":"0000-0001-9401-4005","position":8,"is_corresponding":false},{"id":1006887,"name":"Ann-Margaret Dunn Navarra","orcid":"0000-0002-4633-5135","position":0,"is_corresponding":true}],"reference_count":59,"raw_metadata":null,"created_at":"2026-07-19T02:05:10.907983Z","pmid":"38463238","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}